Tavapadon Recruiting Phase 3 Trials for Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04201093Fixed-Dose Trial in Early Parkinson's Disease (PD)
NCT04223193Flexible-Dose Trial in Early Parkinson's Disease (PD)
NCT04542499Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations